FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
R-tanna Pediatric Suspension Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Use with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, narrow angle glaucoma or prostatic, hypertrophy. Use with caution or avoid use in patients taking monoamine oxidase (MAO) inhibitors, or within 14 days of stopping such treatment. This product contains an antihistamine which may cause drowsiness and may have additive central nervous system (CNS) effects with alcohol or other CNS depressants (e.g., hypnotics, sedatives, tranquilizers).
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
R-Tanna Pediatric Suspension is indicated for symptomatic relief of the coryza and nasal congestion associated with the common cold, sinusitis, allergic rhinitis and other upper respiratory tract conditions. Appropriate therapy should be provided for the primary disease.
History
There is currently no drug history available for this drug.
Other Information
R-Tanna Pediatric Suspension is an antihistamine/nasal decongestant combination available for oral administration as a Suspension. Each 5 mL (one teaspoonful) of the slate-purple-colored, natural strawberry- artificial currant flavored Suspension contains:
Phenylephrine Tannate 5 mg
Chlorpheniramine Tannate 4.5 mg
Other ingredients: benzoic acid, FD and C Blue No. 1, FD and C Red No. 3, FD and C Red No. 40, FD and C Yellow No. 5 (see Precautions), flavors (natural and artificial), glycerin, kaolin, magnesium aluminum silicate, methylparaben, pectin, purified water, saccharin sodium, sucrose.Sources
R-tanna Pediatric Suspension Manufacturers
-
Prasco Laboratories
R-tanna Pediatric Suspension | Prasco Laboratories
Administer the recommended dose every 12 hours.
R-Tanna Pediatric Suspension: Children over six years of age - 5 to 10 mL (1 to 2 teaspoonfuls); Children two to six years of age - 2.5 to 5 mL (1/2 to 1 teaspoonful); Children under two years of age - Titrate dose individually.
Login To Your Free Account